Protein cages are hollow spherical proteins assembled from a defined number of subunits. Because they are extremely homogeneous in size and structure, their interior cavities can serve as ideal templates to encapsulate and synthesize well-defined nanoparticles. Here, we describe the exemplary synthesis of a hard and a soft material in two representative protein cages, i.e., magnetite nanoparticles in ferritin and a poly(2-aminoethyl)methacrylate inside a viral capsid derived from the bacteriophage P22.
Introduction
Biology has provided inspiration for material scientists for years. One of these examples is the synthesis of nano-sized particles [1, 2] , nucleated and constrained within a protein cage-like architecture. Nanoparticles have made a significant impact in material science for the past few decades, because they exhibit unique properties (e.g., magnetic, photonic, and catalytic) different from bulk materials. One of the critical challenges in the preparation of nanoparticles is the control of their size and morphology and, because the emergent properties of nanoparticles are intimately related to their dimension, the homogeneity of the size distribution is critical.
Through millions of years of evolution, nature has developed nano-size cage-like protein assemblies that are designed to encapsulate guest molecules inside and protect them from the external environment. Ferritins that sequester iron as iron oxide particles [3] and viral capsids that encapsulate their nucleic acid genome [4] are examples of protein cages in this category. Material scientists have been inspired from the natural function of protein cages and exploited them as platforms for the development of a wide range of nanomaterials [4] [5] [6] [7] . Cage-like protein structures are ideal templates to synthesize nanoparticles because they have homogeneous size and their interior cavity can provide a confined environment for the selectively directed synthesis or for entrapment of guest molecules. In this chapter, we describe two examples of nanoparticle synthesis in protein cages, the synthesis of magnetite (or maghemite) nanoparticles (hard inorganic materials) in ferritin (Fig. 1a) and the synthesis of a 2-aminoethyl methacrylate (AEMA) polymer, via atom transfer radical polymerization (ATRP), in a viral capsid derived from the bacteriophage P22 (Fig. 2) .
Materials
All solutions should be prepared using ultrapure water (resistivity of 18.2 MΩ cm at 25 C) unless otherwise noted.
Synthesis of Magnetite Nanoparticle in Human Ferritin
1. The apo form of human heavy-chain ferritin (HFn) is heterologously expressed in, and purified from, E. coli (BL21 (DE3)). The cloning, expression, and purification procedure has been described in previous papers [8, 9] . The purified HFn can be 3. Degassed water and 100 mM NaCl: Degas about 30 mL of ultrapure water and 10 mL of 100 mM NaCl (for use in Subheading 3.1, step 3) by bubbling nitrogen (or argon) gas for at least 30 min. Degas the solutions immediately before magnetite synthesis and keep them under a positive pressure of the inert gas. 6. NaOH (100 mM) solution. Weigh 4.00 g NaOH and add to about 900 mL water. Once the NaOH is well dissolved, add 3. ATRP polymer is initiated from a genetically introduced cysteine residue mutated from serine at position 39, which is on the interior of the capsid of wild-type P22 coat protein as described [10] . According to the available P22 structural models, this site is expected to be exposed to the interior cavity [11] and is therefore suitable for attachment of the ATRP initiator (see Note 1) [10, 12] . The procapsid form (PC) of P22 S39C is heterologously expressed in and purified from E. coli (BL21 (DE3)). The cloning, expression, and purification procedure has been previously described [10, 13] . The PC of P22 S39C is transformed to the expanded form (EX) as previously described [10] (see Note 2).
2-Bromoisobutyryl aminoethyl maleimide:
The ATRP initiator, 2-bromoisobutyryl aminoethyl maleimide, is synthesized by a modification of the procedures reported previously [14, 15] . Mix N-2-aminoethylmaleimide (250 mg, 0.98 mmol) with dry triethylamine (300 μl, 2.2 mmol) in 5 ml dry dichloromethane on ice. Add 2-bromo-2-methylpropionylbromide (200 μl, 1.6 mmol) to the reaction dropwise. Allow the reaction to warm to room temperature and then extract three times with dichloromethane and water, followed by drying over anhydrous sodium sulfate. Purify the crude product using column chromatography (silica gel, 10 % ethyl acetate in dichloromethane). 
Methods

Synthesis of Magnetite Nanoparticle in Human Ferritin
1. Make 2 Â 1.0 L solutions of 0.1 M NaCl solution. Dialyze HFn into 1.0 L of 100 mM NaCl for buffer exchange. After 6 h, replace the dialysis solution with fresh 0.1 M NaCl solution and dialyze for an additional 12 h. Filter the HFn through a 0.1 μm syringe filter to remove dust and adjust the concentration to 2 mg/mL with 100 mM NaCl.
2. Insert a pH electrode connected to a pH auto titrator (Brinkmann 718 STAT Titrino) into the mouth of a jacketed (and temperature-controlled) reaction vessel pre-equilibrated at 65 C. Use a PTFE/silicone septum to seal the mouth of the vessel.
3. Add 7.5 mL of degassed 100 mM NaCl and 2.5 mL of the HFn solution prepared above to the vessel under an Ar atmosphere (i.e., final HFn concentration is 0.5 mg/mL) (see Notes 4 and 5). Stir the solution gently with a magnetic stirrer.
4. Load two disposable syringes with 12.5 mM ammonium iron (II) sulfate hexahydrate solution and 4.17 mM hydrogen peroxide solution, respectively. The volumes of the solutions needed depend on the size of the magnetite particle (i.e., iron-loading factor per HFn cage) (see Note 6) . Insert the syringes, with injection tubes, into a syringe pump and insert the tubes into the reaction vessel.
5. Connect the inlet and outlet hoses of the jacketed reaction vessel to a water bath set at 65 C so that temperature of the vessel is brought up to and maintained at 65 C during the mineralization reaction by circulating water through the jacketed flask.
6. Raise the pH of the solution slowly to 8.5 with 100 mM NaOH using the auto titrator. When the pH reaches 8.5, start the simultaneous injection of ammonium iron (II) sulfate hexahydrate and hydrogen peroxide solutions at a constant rate of 100 Fe/(cage · min) (i.e., 79 μL/min) using the syringe pump. H + generated during the reaction is titrated using 100 mM NaOH to maintain the pH at 8.5. The reaction is considered to be completed 5 min after the addition of ammonium iron (II) sulfate hexahydrate and hydrogen peroxide solutions necessary for the targeted iron-loading factor (see Note 7). 2. Add 322 μL of the initiator solution (prepared above) to 24 mL of P22 S39C EX (5 mg/mL) in PBS, pH 7.6 (this corresponds to a fivefold excess per P22 subunit). Gently shake the mixture to react for three hours at room temperature. After 3 h, quench the reaction with DTT (322 μL, 40 mM in water). Pellet the P22 S39C by ultracentrifugation at approximately 209,000 Â g (45,000 rpm) (F50L-8x39 rotor, Piramoon Technologies) for 50 min, to remove any excess of the soluble initiator and DTT, and then resuspend the pellet in 1.0 mL PBS, pH 7.6.
3. Dissolve 160 mg of 2-aminoethyl methacrylate (AEMA) and 40 mg of bis-acrylamide in 4 mL of PBS pH 8.0. Adjust back to pH 8.0 with 2 M NaOH and adjust the volume to 5.0 mL. Spin down the mixture for 1 min at 4,000 Â g to pellet and remove any aggregate.
4. Transfer 4 mL of the AEMA/Bis-acrylamide solution to a 10 mL crimp-top vial and add 2.2 mL of PBS, pH 8.0. Add 1.2 mL of 8.0 mg/mL P22 S39C with the initiator molecule prepared in step 2 to this mixture. Seal the crimp-top vial, followed by a cycle of pumping with a vacuum and back filling with argon gas four times to deaerate the mixture (see Note 8).
5. Add the metal catalyst solution (0.6 mL) to the monomer-P22 S39C mixture anaerobically (under N 2 or Ar) and cover the entire vial in foil, to avoid any photochemical reactions, and maintain the temperature at 23 C for the duration of the polymerization reaction (180 min).
6. Quench the reaction by exposure to air and spin for 5 min at 17,000 Â g to remove any aggregates formed during polymerization. Purify the P22 S39C -polymer composite away from any unreacted monomer and the metal catalyst by pelleting the protein as described previously by ultracentrifugation and resuspend in 1 mL of PBS, pH 8.0. Add 2 mL of the highsalt buffer (250 mM sodium sulfate, 100 mM sodium phosphate, pH 8.0) and agitate gently for 3 h at 4 C to remove any AEMA and bis-acrylamide monomer which might be noncovalently associated with the P22. Pellet the protein again by ultracentrifugation and resuspend in 1.0 mL PBS, pH 8.0. Analyze the obtained material as previously described [10, 12] .
Notes
1. The location of the initiator on a protein cage is critical to achieve confined polymerization inside of the cage cavity.
2. The scaffolding protein of P22 S39C is removed using 0.5 M guanidine-HCl. Ultracentrifuge the P22 S39C at approximately 209,000 Â g for 50 min to pellet the capsid. Resuspend the pellet in 0.5 M guanidine-HCl by rocking gently for 1-2 h at 4 C. Ultracentrifuge the protein again at approximately 209,000 Â g for 50 min [16] . Repeat the cycle of pelleting and resuspension four times. Dialyze the empty-shell (ES) form of P22 against PBS, pH 7.0, overnight. Heat-treat the ES form of P22 for 20 min at 65 C to transform the protein cage into expanded shell (EX) form. Purify the heat treated sample by ultracentrifugation pelleting as above, followed by resuspension into PBS, pH 7.6. Analyze the transformation of the P22 from PC form to EX form as previously described [10, 13, 17] .
3. The catalyst solution should be dark brown to black in color.
Slight blue color suggests insufficient deaeration and could cause poor polymerization.
4. The typical HFn concentration we have described is 0.5 mg/mL, but protein concentrations in the range of 0.1-1 mg/mL work equally well for the synthesis. 7. The color of the mineralized HFn solution should be dark brown if magnetite (or maghemite) has been successfully synthesized in HFn. A bright orange/brown color suggests contamination of the product with ferrihydrite (or other iron oxides) formation. Definitive analysis can be achieved with electron diffraction equipped with transmission electron microscope or X-ray diffraction.
8. Tap the vial during the vacuum pumping cycle to remove air bubbles.
